ExploreWatchlistsPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Pretax margin (%)

KISSEI PHARMACEUTICAL CO.,LTD. (4547)

Market cap
¥192.1B
P/E ratio
11.2x
Kissei Pharmaceutical develops and manufactures prescription drugs while also operating subsidiaries in food products, IT services, and construction.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 2026-1.2-115.11%
Mar 31, 20257.9-2.85%
Mar 31, 20248.1+817.20%
Mar 31, 20230.9+3.08%
Mar 31, 20220.9-82.93%
Mar 31, 20215+31.06%
Mar 31, 20203.8-61.26%
Mar 31, 20199.9-35.70%
Mar 31, 201815.4+14.74%
Mar 31, 201713.4-15.59%
Mar 31, 201615.9+5.48%
Mar 31, 201515.1-21.52%
Mar 31, 201419.2+35.83%
Mar 31, 201314.2+9.90%
Mar 31, 201212.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat